- Home
- OCGN vs ZIMV Comparison
OCGN vs ZIMV Comparison
Compare OCGN & ZIMV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- ZIMV
- Stock Information
- Founded
- OCGN 2013
- ZIMV 2021
- Country
- OCGN United States
- ZIMV United States
- Employees
- OCGN N/A
- ZIMV N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- OCGN Health Care
- ZIMV Health Care
- Exchange
- OCGN Nasdaq
- ZIMV Nasdaq
- Market Cap
- OCGN 278.3M
- ZIMV 262.9M
- IPO Year
- OCGN N/A
- ZIMV N/A
- Fundamental
- Price
- OCGN $1.06
- ZIMV $8.77
- Analyst Decision
- OCGN Strong Buy
- ZIMV Hold
- Analyst Count
- OCGN 3
- ZIMV 2
- Target Price
- OCGN $6.00
- ZIMV $10.00
- AVG Volume (30 Days)
- OCGN 6.3M
- ZIMV 146.2K
- Earning Date
- OCGN 08-07-2025
- ZIMV 07-31-2025
- Dividend Yield
- OCGN N/A
- ZIMV N/A
- EPS Growth
- OCGN N/A
- ZIMV N/A
- EPS
- OCGN N/A
- ZIMV N/A
- Revenue
- OCGN $4,522,000.00
- ZIMV $443,551,000.00
- Revenue This Year
- OCGN N/A
- ZIMV $1.96
- Revenue Next Year
- OCGN N/A
- ZIMV $1.95
- P/E Ratio
- OCGN N/A
- ZIMV N/A
- Revenue Growth
- OCGN N/A
- ZIMV N/A
- 52 Week Low
- OCGN $0.52
- ZIMV $8.15
- 52 Week High
- OCGN $1.98
- ZIMV $22.40
- Technical
- Relative Strength Index (RSI)
- OCGN 59.49
- ZIMV 42.23
- Support Level
- OCGN $1.10
- ZIMV $8.59
- Resistance Level
- OCGN $1.29
- ZIMV $9.34
- Average True Range (ATR)
- OCGN 0.10
- ZIMV 0.25
- MACD
- OCGN -0.00
- ZIMV -0.04
- Stochastic Oscillator
- OCGN 53.06
- ZIMV 12.50
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.